Showing results (1-10 of 826) with videos related to

Sort By:
Pageof 83
Lymphokine and Cytokine Research|April 1, 1992
Increased levels of circulating cytokines in patients with untreated Hodgkin's diseaseA Gause, S Keymis, R Scholz, et al.
Blood|May 1, 1991
Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's diseaseA Gause, C Pohl, A Tschiersch, et al.
International Journal of Cancer|May 15, 1990
Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T-cell leukemia and infectious mononucleosisM Pfreundschuh, C Pohl, C Berenbeck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Soluble CD8, CD25 and CD30 antigens as prognostic markers in patients with untreated Hodgkin's lymphomaA Gause, W Jung, R Schmits, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Experimental therapy in Hodgkin's diseaseA Engert, C Pohl, V Diehl
Leukemia & Lymphoma|August 1, 1992
The clinical significance of cytokines and soluble forms of membrane-derived activation antigens in the serum of patients with Hodgkin's diseaseA Gause, W Jung, S Keymis, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 10, 1996
[Paraproteins and lymphoma in HIV positive patients]C Drees, C Postler, M Schwonzen, et al.
Anticancer Research|May 1, 1991
Idiotype vaccine against Hodgkin's lymphoma: generation and characterization of an anti-idiotypic monoclonal antibody against the Hodgkin-associated (anti-CD 30) monoclonal antibody HRS-3C Pohl, M Sieber, V Diehl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's diseaseL Trümper, W Jung, G Dahl, et al.
Leukemia & Lymphoma|May 1, 1994
Mimicry of the Hodgkin-associated IRAC antigen by an anti-idiotype network: potential use in active immunotherapy of Hodgkin's lymphomaI Schobert, C Renner, M Pfreundschuh, et al.
Pageof 83